ESC Premium Access

Atherothrombotic risk and outcomes following guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome:a post-hoc analysis of the TROPICAL-ACS trial

Presentation

About the speaker

Assistant Professor Konstantinos D Rizas

German Heart Competence Centre, Eberhard-Karls University of Tuebingen, Tuebingen (Germany)
0 follower

3 more presentations in this session

State of the Art - New options in antithrombotic therapy for coronary artery disease

Speaker: Professor K. Newby (Durham, US)

Thumbnail

Frequency, management and outcomes of patients with stable coronary artery disease eligible for COMPASS. An analysis of the CLARIFY registry.

Speaker: Doctor E. Sorbets (Paris, FR)

Thumbnail

Secondary prevention in 2030: will antiplatelets or anticoagulants prevail?

Speaker: Doctor D. Angiolillo (Jacksonville, US)

Thumbnail

Access the full session

Antithrombotic therapy for coronary artery disease: opportunities and challenges

Speakers: Assistant Professor K. Rizas, Professor K. Newby, Doctor E. Sorbets, Doctor D. Angiolillo
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk